Back to Search
DANIELLA OGILVIE, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1164162376Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Mothers' experiences of bottle-feeding: a systematic review of qualitative and quantitative studies.
PMID 19602520·Arch Dis Child·2009
1-meta
Population tobacco control interventions and their effects on social inequalities in smoking: placing an equity lens on existing systematic reviews.
PMID 18505545·BMC Public Health·2008
1-meta
Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 18313293·Bioorg Med Chem Lett·2008
7-preclinical
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
PMID 18182285·Bioorg Med Chem Lett·2008
7-preclinical
Personal and environmental correlates of active travel and physical activity in a deprived urban population.
PMID 18752663·Int J Behav Nutr Phys Act·2008
8-other
Changing community readiness to prevent the abuse of inhalants and other harmful legal products in Alaska.
PMID 18392927·J Community Health·2008
8-other
The 'Walking for Wellbeing in the West' randomised controlled trial of a pedometer-based walking programme in combination with physical activity consultation with 12 month follow-up: rationale and study design.
PMID 18655723·BMC Public Health·2008
2-rct
Perceived characteristics of the environment associated with active travel: development and testing of a new scale.
PMID 18513430·Int J Behav Nutr Phys Act·2008
8-other
The harvest plot: a method for synthesising evidence about the differential effects of interventions.
PMID 18298827·BMC Med Res Methodol·2008
1-meta
Population tobacco control interventions and their effects on social inequalities in smoking: systematic review.
PMID 18426867·Tob Control·2008
1-meta
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 18061446·Bioorg Med Chem Lett·2008
7-preclinical
Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy.
PMID 18483380·Clin Cancer Res·2008
7-preclinical
"Profits before people"? A systematic review of the health and safety impacts of privatising public utilities and industries in developed countries.
PMID 17873221·J Epidemiol Community Health·2007
1-meta
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 17869514·Bioorg Med Chem Lett·2007
7-preclinical
A community prevention intervention to reduce youth from inhaling and ingesting harmful legal products.
PMID 18047181·J Drug Educ·2007
8-other
Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket.
PMID 16380259·Bioorg Med Chem Lett·2006
7-preclinical
Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics.
PMID 16806916·Bioorg Med Chem Lett·2006
7-preclinical
Evaluating health effects of transport interventions methodologic case study.
PMID 16829328·Am J Prev Med·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 140 BERGEN ST STE D-1610
NEWARK, NJ 07103 - Phone
- (973) 972-2151
Quick Facts
- NPI
- 1164162376
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile